U.S. markets closed

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
137.70-2.80 (-1.99%)
At close: 04:00PM EST
136.00 -1.70 (-1.23%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close140.50
Bid135.50 x 800
Ask138.25 x 800
Day's Range135.92 - 140.73
52 Week Range89.00 - 238.55
Avg. Volume2,029,600
Market Cap22.33B
Beta (5Y Monthly)1.19
PE Ratio (TTM)N/A
EPS (TTM)-7.19
Earnings DateApr 23, 2024 - Apr 29, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est154.86
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for ILMN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Illumina, Inc.
    Analyst Report: Illumina, Inc.Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
    Fair Value
    Economic Moat
    12 days agoMorningstar
View more
  • Yahoo Finance

    FTC's suit against Kroger-Albertsons merger will have a 'chilling effect' on M&A activity

    The FTC’s bid to block Kroger’s $25 billion acquisition of Albertsons will have a ‘chilling effect’ on dealmaking activity.

  • Insider Monkey

    Reasons for the Decline of Illumina (ILMN)

    Baron Funds, an investment management company, released its “Baron Opportunity Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund rose 15.10% (Institutional Shares), outperformed the Russell 3000 Growth Index, which gained 14.09%, and the S&P 500 Index, which advanced 11.69%. The fund saw […]

  • Insider Monkey

    Do You Believe in the Growth Prospects of Illumina (ILMN)?

    RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The Russell 1000 Growth Index (RLG) returned 14.16% and the S&P 500 index returned 11.69% during the fourth quarter of 2023, […]